Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol dosing regimens in persistent asthma
NCT01156844Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Mar 2010; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01156844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156844.